Switzerland
Federal Law of December 15, 2000 on Medicinal Products and Medical Devices (status as of October 1, 2010)
| Year of current version: | 2010 |
|---|---|
| Date of entry into force of original text: | January 1, 2002 |
| Date of Text (Enacted): | December 15, 2000 |
| Type of Text: | IP-related Laws: enacted by the Legislature |
| Subject Matter: | Enforcement of IP and Related Laws, Patents (Inventions), Undisclosed Information (Trade Secrets) |
| Notes: | |
| Available Texts: | |
| French | Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (état le 1er octobre 2010) |
| German | Bundesgesetz vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte (stand am 1. Oktober 2010) |
| Historical Versions: | |
| WIPO Lex No.: | CH244 |
![Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (état le 1er octobre 2010), Complete document (pdf) [179 KB]](/shared/images/icon/new/pdf.gif){kind=icon}
Shortcuts
Article 12 grants the protection to the first applicant seeking marketing authorization for medicinal products. Pursuant to Art. 39.3 of the TRIPS Agreement, Article 12. 2 ensures a ten year data exclusivity period for medical products to the first applicant (the holder of the original market approval).
Article 14.3 provides an exclusion from the simplified market authorization procedure for as long as the original preparation is protected by patent.
Articles 61 to 64 concern the undisclosed information including trade secrets and test data related to medicines.'